TC Biopharm (NASDAQ:TCBP – Get Rating) had its price target decreased by HC Wainwright from $9.00 to $7.00 in a research note released on Thursday morning, The Fly reports. TC Biopharm Stock Performance NASDAQ TCBP opened at $1.11 on Thursday. The company’s fifty day moving average is $2.72 and its two-hundred day moving average is […]
TC Biopharm (Holdings) Plc (NASDAQ:TCBP – Get Rating) saw a significant drop in short interest in April. As of April 15th, there was short interest totalling 59,800 shares, a drop of 27.1% from the March 31st total of 82,000 shares. Based on an average trading volume of 536,500 shares, the short-interest ratio is currently 0.1 […]
/PRNewswire/ TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company today laid out a fundamental.
TC Biopharm (Holdings) Plc (NASDAQ:TCBP – Get Rating) was the recipient of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 82,000 shares, an increase of 821.3% from the March 15th total of 8,900 shares. Based on an average daily volume of 1,110,000 shares, […]